IE36995L - Producing attenuated viruses. - Google Patents
Producing attenuated viruses.Info
- Publication number
- IE36995L IE36995L IE721716A IE171672A IE36995L IE 36995 L IE36995 L IE 36995L IE 721716 A IE721716 A IE 721716A IE 171672 A IE171672 A IE 171672A IE 36995 L IE36995 L IE 36995L
- Authority
- IE
- Ireland
- Prior art keywords
- virus
- attenuated
- cattle
- dec
- diluent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1356076 Attenuated virus vaccine; interferon induction BAYER AG 8 Dec 1972 [10 Dec 1971] 56723/72 Heading A5B A virus is attenuated by serial passage on tissue cultures until it will stimulate interferon production without producing specific immunity to the orginial virus. The virus may be I.P.V. virus (otherwise known as infectious pustular vulvovaginitis, Exanthema coitale vesiculosum bovis or cattle blister rash), pseudorabies virus or influenza virus. It may be passaged on calf kidney, suprarenal or testicular tissue. The attenuated virus may be compounded with a liquified gaseous diluent, isotonic fluid, a buffer solution, a liquid having a molecular weight of 200 or more or a solid diluent. The composition may be used as tablets, pills, dragees, capsules, ampoules for intramuscular injection or nasal sprays, or suppositories. They may be applied to cattle or pigs.
[GB1356076A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2161344A DE2161344C3 (en) | 1971-12-10 | 1971-12-10 | Production of virus strains which stimulate the natural defense mechanisms of a host organism without simultaneously having an antigenic effect and medicaments for the prophylaxis and treatment of viral and bacterial infections in humans and animals, containing such a virus strain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE36995L true IE36995L (en) | 1973-06-10 |
| IE36995B1 IE36995B1 (en) | 1977-04-13 |
Family
ID=5827622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1716/72A IE36995B1 (en) | 1971-12-10 | 1972-12-08 | Improvements in and relating to attenuated viruses |
Country Status (22)
| Country | Link |
|---|---|
| JP (2) | JPS6011013B2 (en) |
| AR (1) | AR204075A1 (en) |
| AT (1) | AT326817B (en) |
| AU (1) | AU473209B2 (en) |
| BE (1) | BE792484A (en) |
| BG (1) | BG21417A3 (en) |
| CA (1) | CA988848A (en) |
| CH (1) | CH577558A5 (en) |
| CS (1) | CS189587B2 (en) |
| DD (1) | DD108115A5 (en) |
| DE (1) | DE2161344C3 (en) |
| DK (1) | DK143201C (en) |
| ES (1) | ES409464A1 (en) |
| FR (1) | FR2162637B1 (en) |
| GB (1) | GB1356076A (en) |
| HU (1) | HU167086B (en) |
| IE (1) | IE36995B1 (en) |
| NL (1) | NL178014C (en) |
| PH (1) | PH12597A (en) |
| SE (1) | SE8400283L (en) |
| SU (1) | SU439956A3 (en) |
| ZA (1) | ZA728709B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
-
0
- BE BE792484D patent/BE792484A/en not_active IP Right Cessation
-
1971
- 1971-12-10 DE DE2161344A patent/DE2161344C3/en not_active Expired
-
1972
- 1972-01-01 AR AR245553A patent/AR204075A1/en active
- 1972-12-01 PH PH14135A patent/PH12597A/en unknown
- 1972-12-02 SU SU1853618A patent/SU439956A3/en active
- 1972-12-05 JP JP47121265A patent/JPS6011013B2/en not_active Expired
- 1972-12-05 JP JP47121264A patent/JPS5924137B2/en not_active Expired
- 1972-12-06 BG BG022052A patent/BG21417A3/en unknown
- 1972-12-07 NL NLAANVRAGE7216628,A patent/NL178014C/en not_active IP Right Cessation
- 1972-12-07 CS CS728391A patent/CS189587B2/en unknown
- 1972-12-07 AT AT1041972A patent/AT326817B/en not_active IP Right Cessation
- 1972-12-08 CH CH1791372A patent/CH577558A5/xx not_active IP Right Cessation
- 1972-12-08 GB GB5672372A patent/GB1356076A/en not_active Expired
- 1972-12-08 DK DK615472A patent/DK143201C/en not_active IP Right Cessation
- 1972-12-08 DD DD167455A patent/DD108115A5/xx unknown
- 1972-12-08 FR FR7243868A patent/FR2162637B1/fr not_active Expired
- 1972-12-08 CA CA158,535A patent/CA988848A/en not_active Expired
- 1972-12-08 HU HUBA2833A patent/HU167086B/hu unknown
- 1972-12-08 IE IE1716/72A patent/IE36995B1/en unknown
- 1972-12-08 ZA ZA728709A patent/ZA728709B/en unknown
- 1972-12-09 ES ES409464A patent/ES409464A1/en not_active Expired
- 1972-12-11 AU AU49920/72A patent/AU473209B2/en not_active Expired
-
1984
- 1984-01-20 SE SE8400283A patent/SE8400283L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS4862919A (en) | 1973-09-01 |
| DK143201B (en) | 1981-07-20 |
| DE2161344B2 (en) | 1980-05-08 |
| DE2161344C3 (en) | 1986-10-02 |
| JPS5924137B2 (en) | 1984-06-07 |
| DK143201C (en) | 1981-12-14 |
| SE8400283D0 (en) | 1984-01-20 |
| PH12597A (en) | 1979-06-27 |
| AU473209B2 (en) | 1976-06-17 |
| FR2162637B1 (en) | 1976-07-02 |
| SE8400283L (en) | 1984-01-20 |
| DE2161344A1 (en) | 1973-06-20 |
| ES409464A1 (en) | 1976-03-16 |
| ATA1041972A (en) | 1975-03-15 |
| JPS4862912A (en) | 1973-09-01 |
| NL7216628A (en) | 1973-06-13 |
| AT326817B (en) | 1975-12-29 |
| GB1356076A (en) | 1974-06-12 |
| JPS6011013B2 (en) | 1985-03-22 |
| AU4992072A (en) | 1974-06-13 |
| SU439956A3 (en) | 1974-08-15 |
| IE36995B1 (en) | 1977-04-13 |
| NL178014B (en) | 1985-08-01 |
| CA988848A (en) | 1976-05-11 |
| NL178014C (en) | 1986-01-02 |
| ZA728709B (en) | 1973-08-29 |
| BE792484A (en) | 1973-06-08 |
| DD108115A5 (en) | 1974-09-05 |
| CH577558A5 (en) | 1976-07-15 |
| FR2162637A1 (en) | 1973-07-20 |
| CS189587B2 (en) | 1979-04-30 |
| AR204075A1 (en) | 1975-11-20 |
| BG21417A3 (en) | 1976-05-20 |
| HU167086B (en) | 1975-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE36995L (en) | Producing attenuated viruses. | |
| FR1512339A (en) | Process for the preparation of ceramic products having a low coefficient of expansion | |
| GB1169930A (en) | Improvements in or relating to Lactam Salts | |
| GB1159054A (en) | Process for the preparation of Olefins | |
| USD201181S (en) | Ceiling panel | |
| GB625646A (en) | Improvements in or relating to processes for manufacturing mercaptans and the products thereof | |
| USD140747S (en) | Glass candle holder or article of similar nature | |
| GB1413401A (en) | Influenza vaccine | |
| GB1390650A (en) | Oxazines and thiazines | |
| GB564828A (en) | New vinyl compounds | |
| GB657268A (en) | Improvements in or relating to couplings for tubes and the like | |
| GB942868A (en) | Preparing triethylenediamine | |
| USD144863S (en) | Design for a radio receiver | |
| FR1503745A (en) | Device for suction, purification and evacuation of combustion products | |
| GB1274032A (en) | NOVEL 1-OXA-17alpha-METHYL-A-NOR-GONA-3,9-DIEN-2-ONES, PROCESSES FOR THEIR PREPARATION, AND COMPOSITIONS INCORPORATING THEM | |
| GB1396754A (en) | Process for preparing alpha-keto esters | |
| Vengerovsky | Osteomyelitis of the ilium in children | |
| GB1228185A (en) | ||
| GB1330950A (en) | Synthesis of 1,2-bis-p-carboxyphenoxy ethane | |
| Reh et al. | Possibilities of Calcining Aluminum Trihydrate in the Fluid Bed | |
| Pindak | Effect of statolon-induced interferon on antibody formation | |
| FR1326925A (en) | Process for separating the reaction products of water, boron trifluoride and an inorganic oxide modified by this trifluoride from a liquid hydrocarbon containing these products | |
| ES248501A1 (en) | A process for the electrothermal production of magnesium | |
| JPS51138635A (en) | Process for preparation of styrene oxide | |
| FR2159048A5 (en) | Isoprene polymerisation - to cis-14-polyisoprene using norbornadiene as mol wt controller |